Trial site
Somni bene Institut fuer medizinische Forschung und Schlafmedizin Schwerin GmbH
- 9running trials
- 9closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Narcolepsy8 trials
- Depression6 trials
- Insomnia3 trials
- Diabetic neuropathy1 trial
- Phase
- Phase 28 trials
- Phase 36 trials
- Phase 2/33 trials
- Phase 41 trial
- Status
- Completed9 trials
- Not yet recruiting5 trials
- Recruiting4 trials
- Lead sponsor
- Alkermes Inc.3 trials
- Idorsia Pharmaceuticals Ltd.2 trials
- Seaport Therapeutics2 trials
- Takeda2 trials
- Boehringer Ingelheim International GmbH1 trial
- and 8 more
Running trials
Not yet recruiting
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Enrolling by invitation
Recruiting
Recruiting
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Narcolepsy6 recruiting
- Depression3 recruiting
Closed trials
Completed
A Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy.
Completed
Completed
Completed
Completed
Completed
Efficacy and Tolerability of Tasipimidine in Sleepless Patients
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026